Nanomedicine in Pancreatic Cancer: Current Status and Future Opportunities for Overcoming Therapy Resistance

SIMPLE SUMMARY: Despite access to a vast arsenal of anticancer agents, many fail to realise their full therapeutic potential in clinical practice. One key determinant of this is the evolution of multifaceted resistance mechanisms within the tumour that may either pre-exist or develop during the cour...

Descripción completa

Detalles Bibliográficos
Autores principales: Greene, Michelle K., Johnston, Michael C., Scott, Christopher J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699181/
https://www.ncbi.nlm.nih.gov/pubmed/34944794
http://dx.doi.org/10.3390/cancers13246175

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699181/
https://www.ncbi.nlm.nih.gov/pubmed/34944794
http://dx.doi.org/10.3390/cancers13246175

Ejemplares similares